ReviewFrontiers in oncology2022

Progress on neoadjuvant immunotherapy in resectable non-small cell lung cancer and potential biomarkers.

Xinyu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.